Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reissued by analysts at Liberum Capital in a research note issued on Monday. They presently have a GBX 8,000 ($108.49) price objective on the stock. Liberum Capital’s target price points to a potential upside of 17.61% from the company’s current price.

A number of other analysts have also weighed in on RB. Goldman Sachs Group dropped their price objective on Reckitt Benckiser Group from GBX 8,130 ($110.25) to GBX 7,920 ($107.40) and set a “neutral” rating for the company in a research note on Thursday, September 21st. Morgan Stanley reaffirmed an “overweight” rating and issued a £100 ($135.61) price target on shares of Reckitt Benckiser Group in a research note on Thursday, September 21st. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a research note on Thursday, September 28th. JPMorgan Chase & Co. set a GBX 6,900 ($93.57) price target on Reckitt Benckiser Group and gave the stock a “neutral” rating in a research note on Thursday, September 28th. Finally, UBS Group set a GBX 7,250 ($98.32) price target on Reckitt Benckiser Group and gave the stock a “neutral” rating in a research note on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of GBX 7,664.55 ($103.94).

Shares of Reckitt Benckiser Group (LON:RB) opened at GBX 6,802 ($92.24) on Monday. The firm has a market capitalization of $47,860.00 and a P/E ratio of 2,274.92. Reckitt Benckiser Group has a 52 week low of GBX 6,299 ($85.42) and a 52 week high of GBX 8,110.43 ($109.99).

In related news, insider Adrian Nevil Hennah purchased 2,285 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, November 8th. The stock was purchased at an average cost of GBX 6,567 ($89.06) per share, for a total transaction of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair purchased 2,800 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, November 1st. The shares were bought at an average price of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34).

TRADEMARK VIOLATION NOTICE: “Reckitt Benckiser Group (RB) Receives “Buy” Rating from Liberum Capital” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/01/15/reckitt-benckiser-group-rb-receives-buy-rating-from-liberum-capital.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.